Going anti-Viral

Episode 4 - A Deep Dive Into Vaccine Development with Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH. Recorded Live From The 2023 RWHAP CLINICAL CONFERENCE in Portland, OR, December 2, 2023

December 06, 2023 Going anti-Viral Season 1 Episode 4
Episode 4 - A Deep Dive Into Vaccine Development with Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH. Recorded Live From The 2023 RWHAP CLINICAL CONFERENCE in Portland, OR, December 2, 2023
Going anti-Viral
More Info
Going anti-Viral
Episode 4 - A Deep Dive Into Vaccine Development with Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH. Recorded Live From The 2023 RWHAP CLINICAL CONFERENCE in Portland, OR, December 2, 2023
Dec 06, 2023 Season 1 Episode 4
Going anti-Viral

Episode 4 - A Deep Dive Into Vaccine Development With Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH. This special episode was recorded live from the 2023 Ryan White CLINICAL CONFERENCE in Portland, OR, December 2nd, 2023

In this special episode of Going anti-Viral, recorded live from the 2023 Ryan White CLINICAL CONFERENCE in Portland, OR, we explore the challenges and progress in developing vaccines for HIV and COVID-19. Dr Saag discusses with Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH, about vaccine development for HIV and its associated challenges and how pre-existing knowledge of similar viruses expedited COVID-19 vaccine development. The conversation also touches upon cellular immunity, broadly neutralizing antibodies, and the potential future of HIV vaccine development.

00:08 Introduction and Welcome
00:44 Interview with Dr Richard Koup
01:05 The History of HIV Vaccine Development
02:26 The Challenges of HIV Vaccine Development
06:33 The Role of Broadly Neutralizing Antibodies in HIV Vaccine Development
14:30 The Potential of Cellular Immunity in HIV Vaccine Development
16:08 The Miraculous Development of the COVID-19 Vaccine
26:37 The Future of HIV Vaccine Development
28:13 Conclusion and Closing Remarks

__________________________________________________

Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

Follow Going anti-Viral on:
Apple Podcasts
YouTube
Instagram
TikTok
...

Show Notes

Episode 4 - A Deep Dive Into Vaccine Development With Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH. This special episode was recorded live from the 2023 Ryan White CLINICAL CONFERENCE in Portland, OR, December 2nd, 2023

In this special episode of Going anti-Viral, recorded live from the 2023 Ryan White CLINICAL CONFERENCE in Portland, OR, we explore the challenges and progress in developing vaccines for HIV and COVID-19. Dr Saag discusses with Dr Richard Koup, Deputy Director Chief, Immunology Laboratory Vaccine Research Center, NIAID, NIH, about vaccine development for HIV and its associated challenges and how pre-existing knowledge of similar viruses expedited COVID-19 vaccine development. The conversation also touches upon cellular immunity, broadly neutralizing antibodies, and the potential future of HIV vaccine development.

00:08 Introduction and Welcome
00:44 Interview with Dr Richard Koup
01:05 The History of HIV Vaccine Development
02:26 The Challenges of HIV Vaccine Development
06:33 The Role of Broadly Neutralizing Antibodies in HIV Vaccine Development
14:30 The Potential of Cellular Immunity in HIV Vaccine Development
16:08 The Miraculous Development of the COVID-19 Vaccine
26:37 The Future of HIV Vaccine Development
28:13 Conclusion and Closing Remarks

__________________________________________________

Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.

Going anti-Viral’s host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences.

Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.

Follow Going anti-Viral on:
Apple Podcasts
YouTube
Instagram
TikTok
...